AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2637-8876/008
Deportment of Medicinal Chemistry, Browns College of pharmacy, Khammama,
*Corresponding Author: Saritha Garrepally, Deportment of Medicinal Chemistry, Browns College of pharmacy, Khammama, Email: sarithagarrepalli@gmail.com
Citation: Saritha Garrepally and Garrepally Prasad. P38 MAPK and Its Upstream Activators MKK3 and MKK6 Play an Important Role on Lipopolysaccharide-Induced RANKL Expression by Periodontal Ligament Cells, J Immunology and Inflammation Diseases Therapy. DOI: 10.31579/2637-8876/008
Copyright: © 2017 Saritha Garrepally. This is an open-access article distributed under the terms of The Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction inany medium, provided the original author and source are credited.
Received: 26 April 2017 | Accepted: 22 May 2017 | Published: 26 May 2017
Keywords: lipopolysaccharide; porphyromonas gingivalis; cell signaling; RANKL; OPG
Resident, non-immune cells express various pattern-recognition receptors and produce inflammatory cytokines in response to microbial antigens, during the innate immune response. Alveolar bone resorption is the hallmark of destructive periodontitis and it is caused by the host response to bacteria and their mediators present on the biofilm. The balance between the expression levels of receptor activator of nuclear factorkappa B ligand (RANKL) and osteoprotegerin (OPG) is pivotal for osteoclast differentiation and activity and has been implicated in the progression of bone loss in periodontitis. To assess the contribution of resident cells to the bone resorption mediated by innate immune signaling, we stimulated fibroblasts and osteoblastic cells with LPS from. Escherichia coli (TLR4 agonist), Porphyromonas gingivalis (TLR2 and -4 agonist), and interleukin-1 beta (as a control for cytokine signaling through Toll/IL-1receptor domain) in time-response experiments. Expression of RANKL and OPG mRNA was studied by RT-PCR, whereas the production of RANKL protein and the activation of p38 MAPK and NF-kB signaling pathways were analyzed by western blot. We used biochemical inhibitors to assess the relative contribution of p38 MAPK and NF-kB signaling to the expression of RANKL and OPG induced by TLR2, -4 and IL1β in these cells. Both p38 MAPK and NFkB pathways were activated by these stimuli in fibroblasts and osteoblasts, but the kinetics of this activation varied in each cell type and with the nature of the stimulation. E. coli LPS was a stronger inducer of RANKL mRNA in fibroblasts, whereas LPS from P. gingivalis downregulated RANKL mRNA in periodontal ligament cells but increased its expression in osteoblasts. IL-1β induced RANKL in both cell types and without a marked effect on OPG expression. p38 MAPK was more relevant than NF-kB for the expression of RANKL and OPG in these cell types.
The essential role of RANKL/RANK/OPG axis in osteoclast differentiation/activation in inflammatory bone diseases, including periodontal disease is widely acknowledged [1]. In the inflamed periodontal microenvironment, various cell types are capable of expressing RANKL, including periodontal ligament fibroblasts, leading to tissue destruction through activation of RANK on pre-osteoclasts [2]. In fact, increased expression of RANKL associated with reduced expression of OPG was observed in both animal models [3] and human periodontallydiseased sites [1]. Specifically in periodontal disease, bacterial lipopolysaccharide (LPS) of Gram-negative microorganisms has shown both in vitro [4] and in vivo [5] an important role in damage process by inducing the expression of various inflammatory mediators including: IL-1, IL-6 and IL-8 [6], which can indirectly promote RANKL expression which ultimately result in alveolar bone loss that was initiated by Toll-like receptors (TLRs) signaling [7]. LPS from Gram-negative bacteria of the subgingival biofilm associated with periodontal disease activate both TLR2 and -4 [8,9]. We have previously shown that TLR4 stimulation in periodontal ligament fibroblasts result in increased RANKL expression, which is at least partially dependent on p38 MAPK signaling [10]. In the periodontal tissues, gingival fibroblasts (GF) [11], periodontal ligament fibroblasts (PDL) [12] and osteoblasts [13] were shown to express TLR2 and TLR4 constitutively, which indicates that these cells are responsive to bacterial LPS [6]. In this context, these cell types that are classically thought of as contributing to periodontal tissue homeostasis [14] can also participate in bone resorption during microbial aggression through secretion of many immunoregulatory cytokines [15]. Some of the cytokines produced by these resident cell types, such as IL-6 [16], may not only act synergistically with the pathogen-associated molecular patterns in the activation of dendritic cells and modulation of the adaptive immune response, but can also have direct effects on of tissue degradation and bone resorption. Other inflammatory mediators and cytokines produced by the resident cell types in response to TLR signaling may have primarily direct effects on the modulation of tissue degradation, including matrix metalloproteases, PGE2 and RANKL. Thus, the cytokine network associated with diseased periodontal tissues is highly complex, and it is currently thought that the cytokine profile ultimately determines disease activity [17]. This cytokine profile is the consequence of the activation of different signaling pathways by a multitude of external signals present in the periodontal microenvironment, resulting in a signaling network that modulates cytokine production. Considering the infectious nature of periodontal disease and the crucial role of bacterial LPS as a ubiquitous and chronically present microbial stimulus activating TLR2 and -4, we studied LPS-induced activation of signaling pathways that are especially relevant for expression of inflammatory genes. LPS stimulation may have a positive role in the modulation of osteoclastogenesis by inducing RANKL and/or inhibiting OPG expression or a negative role by reducing the expression of RANK or M-CSF receptor on osteoclast precursor cells [18]. In human gingival fibroblasts, LPS had a bone-protective effect by inducing the production of OPG [19]. In this study we present data on the differential regulation of RANKL and OPG gene expression after activation of TLR2, -4 and IL1R in fibroblasts and osteoblasts, providing insight into the relative contribution of p38 MAPK and NF-kB signaling to the expression of these genes in each cell type.
Material and methods
Mouse periodontal ligament fibroblasts (mPDL), immortalized with simian vírus 40 large T antigen, were originally obtained from Dr Martha J. Somerman (NIH/NIDCR, Bethesda, MD, USA). These cells were previously characterized for the expression of genes normally expressed by primary periodontal ligament cells, including bone sialoprotein, osteopontin, osteocalcin and type I collagen. Osteoblastic rat osteosarcoma cells ROS 17/2.8 (ROS) were obtained from Dr. Laurie McCauley (University of Michigan, Ann Arbor, MI, USA). Osteoblast phenotypic mRNAs, including bone sialoprotein and osteocalcin, were routinely assayed to verify osteoblastic phenotype expression in these cells. Unless noted otherwise, all tissue culture reagents were obtained from Invitrogen/Life Technologies (Carlsbad, CA, USA). Lipopolysaccharide from Escherichia coli (serotype O55:B5) was purchased from Sigma-Aldrich (St Louis, MO, USA) and Porphyromonas gingivalis lipopolysaccharide was purchased from Invivogen (San Diego, CA, USA). Biochemical inhibitors of p38 MAPK (SB203580) and NF-kB (Bay-110782) were purchased from Sigma-Aldrich (St Louis, MO, USA). Both E. coli and P. gingivalis lipopolysaccharide were diluted in RNAse-free water to 5 mg/mL. Recombinant human Interleukin-1b protein was from R&D systems (Minneapolis, MN, USA) and was diluted in PBS containing 0.1% BSA. All primer pairs were purchased from Invitrogen/Life Technologies (Carlsbad, CA, USA). Mouse RANKL monoclonal antibody was obtained from Imgenex (San Diego, California, USA). Phosphorylated p38 monoclonal antibody was from Cell Signaling (Danvers, MA, USA), whereas the monoclonal antibody for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and the polyclonal antibody for phosphorylated p50 were from Santa Cruz Biotechnology (Santa Cruz, CA, USA).
Both mPDL and Ros17/2.8 cells were grown in Dulbecco's Modified Eagle's Medium supplemented with 100 IU/mL of penicillin, 100 ug/mL of streptomycin and 10% heat-inactivated fetal bovine serum, and maintained in a humidified atmosphere at 37°C and 5% CO2. After plating, the cells were left to attach overnight in complete growth medium, routinely de-induced in medium containing 0.3% FBS for 6 h and then stimulated with the indicated concentrations of the agonists and for the indicated periods. In the experiments assessing the role of p38 MAPK and NF-kB on RANKL and OPG gene expression, 10 uM of either SB203580 or Bay-110782 were added to the cultures 30 min before the stimulation with the LPSs or IL-1b. All experiments were performed in duplicate and repeated in an independent manner a minimum of three times.
Semi-quantitative RT-PCR
Total RNA was isolated from cells using Trizol (Invitrogen) according to the manufacturer's instructions. The quantity and purity of total RNA were determined on a Biomate 3 (Thermo Electron Corporation) spectrophotometer. Complementary DNA was synthesized by reverse transcription of 500 ng of total RNA using 2.5 µM Oligo (dT) 12-18 primers and 1.25 U/uL Moloney murine leukemia virus reverse transcriptase in the presence of 3 mM MgCl2, 2 mM dNTPs and 0.8 U/µL of RNAse inhibitor, according to the manufacturer's protocol (Improm II – Promega). The PCR reaction was performed in a MyCycler (Bio-Rad) thermocycler using 2uL of the RT reaction product on a 25 uL total volume PCR reaction mix (GoTaq Flexi, Promega). It was used 100 pmol/ul of each gene's primers (50 pmol/ul of sense and antisense primers) for RANKL, OPG and GAPDH genes yielding products of 467, 140, 503 and 418 bp for RANKL (mouse - mPDL) , RANKL (rat - ROS) OPG and GAPDH, respectively. The primer pair used for RANKL–mouse-(accession no.: NM011613) was: sense 5'-CAGCACTCACTGCTTTTATAGAATCC- 3';antisense 5'-AGCTGAAGATAGTCTGTAGGTACGC-3'; for RANKL–rat-(accession no.: NM057149) was: sense 5'- TCGGGTTCCCATAAAGTCAG-3', antisense 5'-CTGAAGCAAATGTTGGCGTA, for osteoprotegerin (accession no: NM008764) was: sense 5'- TGTAGAGAGGATAAACGG - 3'; antisense 5'- CTAGTTATATGCAGCTTAT-3'; and for GAPDH (accession no.: BC083065) was: sense 5'-CACCATGGAGAAGGCCGGGG-3'; antisense 5'- GACGGA-CACATTGGGGTAG- 3'. Optimyzed cycling conditions used for RANKL (from mouse) and OPG were: initial denaturation at 95°C for 2 min and 30 cycles (35 cycles for OPG) of: 95°C for 1 min, 56°C for 1 min, 72°C for 2 min, and a final extension step at 72°C for 7 min in the presence of 2.5 mM MgCl2, whereas for RANKL (from rat) the cycling conditions were as follows: initial denaturation at 95°C for 2 min and 40/36 cycles of: 95°C for 15 sec, 58°C for 30 sec, 72°C for 30 sec and a final extension step at 72°C for 7 min in the presence of 2.5 mM MgCl2. For GAPDH, RT thermocycler conditions were as follows: initial denaturation at 95°C for 2 min and 25 cycles of: 95°C for 1 min, 52°C for 1 min, 72°C for 1 min and a final extension step at 72°C for 10 min in the presence of 1.5 mM MgCl2. The PCR products were resolved by electrophoresis on 1.5% (w/v) agarose gels containing ethidium bromide (0.5µg/mL). The amplified DNA bands were analyzed densitometrically after digital imaging capture (Image Quant 100 – GE Healthcare), using Image J 1.45s software (National Institute of Health, The density of the bands corresponding to RANKL and OPG mRNA in each sample was normalized to the amount of the housekeeping gene GAPDH and expressed as fold change over unstimulated control.
Statistical analysis
Pairwise comparisons between experimental groups were performed using the t-test with Welch's correction for unequal variances. Comparison between fold changes on mRNA expression between lipopolysaccharide-stimulated and untreated cells was performed with the one-sample t-test. The significance level was set to 5% and all calculations were performed using PRISM 4 software (GraphPad, Inc., San Diego, CA, USA).
Results
Differential activation of NF-κB and p38 MAPK by TLR2, -4 and IL1R
TLR4, TLR2 and IL1R signaling was induced by stimulating both osteoblastic and fibroblastic cells with LPS from E. coli, LPS from P. gingivalis and with rhIL-1β, respectively. In periodontal ligament fibroblasts, activation of p38 MAPK was biphasic using either LPS or IL-1β. However, TLR signaling resulted in delayed activation of p38 in comparison to IL-1R signaling (10 and 60 minutes for IL-1R versus 20 and 120 minutes for TLR signaling; Figure 1A). Interestingly, activation of p38 MAPK was more intense with the lower concentration of LPS (100 ng/mL), whereas the higher concentration of LPS (1 µg/mL) resulted in a time-dependent activation with less evident peaks. In osteoblastic cells, TLR2 signaling was a more potent activator of p38 and NF-kB than TLR4 signaling. Stimulation of IL-1R in these cells was of intermediary potency in comparison to TLR2 and TLR4, but similarly to the fibroblasts resulted in more rapid and transitory activation, in particular of NF-kB (Figure 1B).
Figure 1: Representative image of three independent western blot experiments for nuclear factor-kappa B p50 (NF-κB) and p38 mitogen-activated protein kinase (MAPK) evaluation.
RANKL and OPG mRNA expression
Activation of TLR4 signaling in periodontal ligament fibroblasts resulted in a concentration-dependent increase on RANKL mRNA expression in later experimental periods (Figure 2A), whereas OPG mRNA levels were not affected. In contrast, TLR2 signaling significantly inhibited RANKL mRNA expression in these cells (Figure 2B), returning to basal/constitutive levels only 24 hours after stimulation with P. gingivalis LPS. There was also a trend to decrease OPG mRNA expression with activation of TLR2 signaling, but this inhibition was not as marked as for RANKL. In IL-1β-stimulated periodontal ligament fibroblasts a more rapid induction of RANKL mRNA occurred with both IL-1β concentrations (Figure 2C), followed by a decrease in later experimental periods (18 and 24h). A discrete and rapid increase of OPG mRNA expression was also observed in earlier experimental periods, particularly with the higher concentration of IL-1β.
Figure 2 : Time course of receptor activator of nuclear factor-kappa B ligand (RANKL) and osteoprotegerin (OPG) mRNA expression induced by Escherichia coli (A), Porphyromonas gingivalis (B) and interleukin-1 beta (C) in periodontal ligament cells (mPDL).
Activation of TLR4 signaling in periodontal ligament fibroblasts resulted in a concentration-dependent increase on RANKL mRNA expression in later experimental periods (Figure 2A), whereas OPG mRNA levels were not affected. In contrast, TLR2 signaling significantly inhibited RANKL mRNA expression in these cells (Figure 2B), returning to basal/constitutive levels only 24 hours after stimulation with P. gingivalis LPS. There was also a trend to decrease OPG mRNA expression with activation of TLR2 signaling, but this inhibition was not as marked as for RANKL. In IL-1β-stimulated periodontal ligament fibroblasts a more rapid induction of RANKL mRNA occurred with both IL-1β concentrations (Figure 2C), followed by a decrease in later experimental periods (18 and 24h). A discrete and rapid increase of OPG mRNA expression was also observed in earlier experimental periods, particularly with the higher concentration of IL-1β.
In the periodontal disease microenvironment, the ubiquitous presence of various MAMPs and the widespread expression of PRRs by immune and non-immune cell types suggest that innate immune signaling in 'non-professional'/resident cell types play a role modulating the host response. Importantly, cell type and differentiation state can influence both the expression of PRR, and also the signaling pathways activated by the same MAMPs [20].
Our research group has previously shown that p38 MAPK and its upstream activators MKK3 and MKK6 play an important role on lipopolysaccharide-induced RANKL expression by periodontal ligament cells [10], and in this study, we report that signaling through TLR2, TLR4 and IL1R results in differential modulation of RANKL gene expression. Moreover, a biphasic activation of p38 MAPK with delayed kinetics is associated with TLR signaling. The delayed activation of p38 MAPK upon TLR4 signaling is associated with a delayed induction of RANKL mRNA in comparison to IL1R signaling. Moreover, TLR4-induced expression of RANKL mRNA in fibroblasts was primarily dependent on p38 MAPK activation. A previous study suggested that RANKL and OPG expression in periodontal ligament cells was indirectly induced by the production of IL-1β and TNF-α 6 hours after LPS stimulation [21]. Our data show that induction of RANKL mRNA occurred mostly 8 hours or more subsequent to stimulation, so we cannot rule out a possible autocrine/paracrine influence by early-response genes in our results. Consistent with this possibility, when stimulated with IL-1β both periodontal ligament fibroblasts and osteoblasts showed a more rapid increase of RANKL mRNA. However, at the protein level these different agonists showed varying potencies in each cell type. E. coli LPS potently induced RANKL protein in osteoblastic cells, whereas IL-1b was a stronger inducer in periodontal ligament fibroblasts. It is tempting to speculate on potentially different roles for these cell types in periodontal disease based on their differential response to the same agonists: osteoblasts were more responsive to TLR signaling and periodontal ligament cells more sensitive to inflammatory mediators, e.g., IL-1, that may be produced in response to the initial bacterial challenge or in situation associated with mechanical stress such as orthodontic movement or traumatic occlusion. Activation of nuclear factor-kappa B (NF-κB) followed a similar pattern regardless of cell type, suggesting it is receptor-dependent with distinct results for TLR or IL1R stimulation. In both periodontal ligament fibroblasts and osteoblastic cells only IL1R signaling resulted in biphasic activation of NF-kB (especially with the lower concentration of IL-1b), whereas TLR2 and TLR4 signaling was associated with a more sustained activation over time. IL-1β signaling through IL1R may also follow an alternative pathway that is associated with the second peak of activation of NF-kB representing delayed NF-κB activation through TAK1, which, together with TRAF6, is also an upstream activator of MAPKinases [22]. Interestingly, regulation of RANKL and OPG mRNA induced by TLR2, -4 and IL1R was primarily dependent on p38 MAPK in both fibroblasts and osteoblasts; with NF-kB activation, a major downstream signaling effector of TLRs and IL1R, having a more prominent role on IL1b-induced RANKL mRNA expression by fibroblasts.
The inhibitory effect of on RANKL mRNA upon stimulation with P. gingivalis LPS is both unexpected and intriguing. It is possible that this effect may represent a cell-type specific effect, as this inhibition was not observed in osteoblastic cells stimulated with P. gingivalis LPS. Interestingly, downregulation of RANKL and increased OPG mRNA expression was already reported in cementoblasts stimulated with P. gingivalis LPS [23]. We did not find consistent changes of great magnitude on OPG mRNA expression on fibroblasts and osteoblasts, suggesting that the agonists used to activate TLR and IL1R signaling did not evoke a protective feedback mechanism to maintain bone homeostasis. The relatively minor changes in OPG expression further suggests that the ultimate outcome of bone turnover induced by these agonists might be determined by the changes on the expression of RANKL.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
